KALV Congressional Stock Trades
KalVista Pharmaceuticals, Inc. (KALV)
Last disclosed trade Dec 12
Every disclosed trade in KALV by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
Christopher L. Jacobs · Bought $KALV · Dec 12 · $1K–$15K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $KALV
Get notified when any member of Congress trades $KALV. Free, no card, no spam.
The record on $KALV
Coldpine has parsed 1 disclosed trade in $KALV by 1 member of Congress, drawn from 1 periodic transaction report dated Dec 12, 2022. It came from the House, filed by a Democrat.
The one trade with a known filing lag was reported 39 days after the trade date, inside the 45-day window the STOCK Act sets: a $KALV purchase by Christopher L. Jacobs dated Dec 12, 2022, disclosed Jan 20, 2023. How late filing is measured across all of Congress is in the late-filers study.
Members who trade KALV
Recent disclosed trades in KALV
| Date | Member | Type | Amount |
|---|---|---|---|
| Dec 12 | Christopher L. Jacobs(NY) | buy | $1K–$15K |
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →